REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneka Farmasiyutikalz OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Astrazeneka Farmasiyutikalz OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Astrazeneca Pharmaceutic LTD is an international research-based biopharmaceutical company focused on the research, development, and market introduction of prescription drugs primarily in therapeutic areas such as oncology, cardiology, nephrology and metabolism, respiratory and autoimmune, as well as rare diseases. The company, based in Cambridge, United Kingdom, is present in over 100 countries worldwide, and its innovative drugs are used by millions of patients around the world.

Headquarters
1-i Krasnogvardeiskii, 21, 1, 30 Kom 13-14
Moscow; Moscow; Postal Code: 123112

Contact Details: Purchase the Astrazeneka Farmasiyutikalz OOO report to view the information.

Website: http://astrazeneca.ru

Basic Information
Total Employees:
Purchase the Astrazeneka Farmasiyutikalz OOO report to view the information.
Outstanding Shares:
Purchase the Astrazeneka Farmasiyutikalz OOO report to view the information.
Registered Capital:
Purchase the Astrazeneka Farmasiyutikalz OOO report to view the information.
Financial Auditors:
Purchase the Astrazeneka Farmasiyutikalz OOO report to view the information.
Incorporation Date:
November 25, 2005
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Target Medikals OOO
8.695%
Company Performance
Financial values in the chart are available after Astrazeneka Farmasiyutikalz OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
25.73%
Total operating revenue
25.73%
Operating profit (EBIT)
662.23%
Net Profit (Loss) for the Period
N/A
Total assets
12.85%
Total equity
6.27%
Operating Profit Margin (ROS)
11.23%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.18%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?